Suppr超能文献

中国的心力衰竭:流行病学与当前治疗

Heart failure in China: epidemiology and current management.

作者信息

Hu Sheng-Shou

机构信息

Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

出版信息

J Geriatr Cardiol. 2024 Jun 28;21(6):631-641. doi: 10.26599/1671-5411.2024.06.008.

Abstract

The (2022) intricate landscape of cardiovascular health in China. In connection with the previous section, this sixth section of the report offers a comprehensive analysis of heart failure (HF) in China. HF is one of the most important cardiovascular disease in the 21 century. Its mortality is equivalent to that of cancer. It is an important public health problem that seriously affects the health of Chinese residents. In recent years, with the deepening of understanding, the change of treatment principles, the innovation of treatment methods and the update of treatment guidelines, the in-hospital mortality of HF patients has declined, and the long-term prognosis is also improving. However, there are still differences in the management level of HF among different hospitals in China. How to improve the standardized diagnosis and treatment level of HF in China remains an important challenge.

摘要

《2022年中国心血管健康的复杂状况》。与上一节相关,本报告的第六节对中国的心力衰竭(HF)进行了全面分析。心力衰竭是21世纪最重要的心血管疾病之一。其死亡率与癌症相当。它是一个严重影响中国居民健康的重要公共卫生问题。近年来,随着认识的深入、治疗原则的改变、治疗方法的创新以及治疗指南的更新,心力衰竭患者的院内死亡率有所下降,长期预后也在改善。然而,中国不同医院在心力衰竭管理水平上仍存在差异。如何提高中国心力衰竭的规范化诊疗水平仍然是一项重大挑战。

相似文献

1
Heart failure in China: epidemiology and current management.
J Geriatr Cardiol. 2024 Jun 28;21(6):631-641. doi: 10.26599/1671-5411.2024.06.008.
2
Understanding the economic burden of heart failure in China: impact on disease management and resource utilization.
J Med Econ. 2017 May;20(5):549-553. doi: 10.1080/13696998.2017.1297309. Epub 2017 Mar 12.
3
Epidemiology and current management of cerebrovascular disease in China.
J Geriatr Cardiol. 2024 May 28;21(5):465-474. doi: 10.26599/1671-5411.2024.05.009.
4
Pulmonary embolism and deep venous thrombosis in China.
J Geriatr Cardiol. 2024 Aug 28;21(8):775-778. doi: 10.26599/1671-5411.2024.08.007.
6
Epidemiology and current management of cardiovascular disease in China.
J Geriatr Cardiol. 2024 Apr 28;21(4):387-406. doi: 10.26599/1671-5411.2024.04.001.
10
Heart failure in China: a review of the literature.
Drugs. 2013 May;73(7):689-701. doi: 10.1007/s40265-013-0057-8.

引用本文的文献

1
Implementation of Early Mobilization in Post-CABG Patients: A Constructivist Grounded Theory Study.
Patient Prefer Adherence. 2025 Aug 30;19:2697-2709. doi: 10.2147/PPA.S537861. eCollection 2025.
4
Association between inflammatory burden index and risk of heart failure: evidence from NHANES 2003-2017.
BMC Cardiovasc Disord. 2025 Apr 24;25(1):318. doi: 10.1186/s12872-025-04781-x.
5
Role of metabolic dysfunction-associated fatty liver disease in atrial fibrillation and heart failure: molecular and clinical aspects.
Front Cardiovasc Med. 2025 Apr 8;12:1573841. doi: 10.3389/fcvm.2025.1573841. eCollection 2025.

本文引用的文献

1
Three-dimensional electroanatomical mapping guidelines for the selection of pacing site to achieve cardiac resynchronization therapy.
Front Cardiovasc Med. 2022 Sep 30;9:843969. doi: 10.3389/fcvm.2022.843969. eCollection 2022.
2
Randomized Trial of Left Bundle Branch vs Biventricular Pacing for Cardiac Resynchronization Therapy.
J Am Coll Cardiol. 2022 Sep 27;80(13):1205-1216. doi: 10.1016/j.jacc.2022.07.019.
4
Sustained-Release Ivabradine Hemisulfate in Patients With Systolic Heart Failure.
J Am Coll Cardiol. 2022 Aug 9;80(6):584-594. doi: 10.1016/j.jacc.2022.05.027.
5
[Chinese expert consensus on clinical application of angiotension-neprilysin inhibitor in patients with heart failure].
Zhonghua Xin Xue Guan Bing Za Zhi. 2022 Jul 24;50(7):662-670. doi: 10.3760/cma.j.cn112148-20211124-01015.
6
[Chinese experts consensus on the comprehensive management of chronic heart failure in female].
Zhonghua Xin Xue Guan Bing Za Zhi. 2022 Jul 24;50(7):653-661. doi: 10.3760/cma.j.cn112148-20211130-01029.
8
Prognostic value of high-sensitivity cardiac troponin I in patients with non-ischaemic heart failure: insights from China.
ESC Heart Fail. 2022 Oct;9(5):3345-3357. doi: 10.1002/ehf2.14065. Epub 2022 Jul 13.
10
Association of On-Admission Anemia With 1-Year Mortality in Patients Hospitalized With Acute Heart Failure: Results From the HERO Study.
Front Cardiovasc Med. 2022 May 4;9:856246. doi: 10.3389/fcvm.2022.856246. eCollection 2022.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验